MRK - Merck & Co., Inc.

Day 1m 10m 60m PreMarket Market AfterHours Gap
84.92 -0.83 (-0.98%) --- --- --- -0.82 (-0.97%) -0.07 (-0.08%) -0.02 (-0.02%) -0.02 (-0.02%)

Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform, led by Keytruda, is a major contributor to overall sales. The company also has a substantial vaccine business aimed at preventing pediatric diseases, as well as Gardasil for human papillomavirus. Additionally, Merck sells animal health-related drugs. From a geographical perspective, 47% of the company's sales are generated from US human health (pharmaceuticals and vaccines).

Category: PHARMACEUTICAL PREPARATIONS
Market Period: Closed

Earnings & Ratios

Basic EPS:
1.76
Diluted EPS:
1.76
Basic P/E:
47.7785
Diluted P/E:
47.7785
RSI(14) 1m:
0.0
VWAP:
84.09
RVol:
0.5733

Events

Period Kind Movement Occurred At

Related News